NCT06859359 Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria
| NCT ID | NCT06859359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Hypertensive Disorder of Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,200 participants in total. It began in 2024-08-08 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?
Eligibility Criteria
Inclusion Criteria: * Postpartum adults (\>18 years) * postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services) * with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent. Exclusion Criteria: * unable to provide consent.
Contact & Investigator
Zainab Mahmoud, MD, MSc
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT06859359 clinical trial?
This trial is open to female participants only, studying Hypertensive Disorder of Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06859359 currently recruiting?
Yes, NCT06859359 is actively recruiting participants. Contact the research team at dike.ojji@uniabuja.edu.ng for enrollment information.
Where is the NCT06859359 trial being conducted?
This trial is being conducted at Abuja, Nigeria, Abuja, Nigeria, Kano, Nigeria, Kano, Nigeria.
Who is sponsoring the NCT06859359 clinical trial?
NCT06859359 is sponsored by Washington University School of Medicine. The principal investigator is Zainab Mahmoud, MD, MSc at Washington University School of Medicine. The trial plans to enroll 1,200 participants.